Cohance Lifesciences Limited (BOM:543064)
India
· Delayed Price · Currency is INR 1,078.65
+19.15 (1.81%)
At close: May 9, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 275.39 billion as of May 13, 2025. Its market cap has increased by 67.60% in one year.
Market Cap
275.39B
Enterprise Value
269.72B
Revenue
10.48B
Ranking
n/a
PE Ratio
98.62
Stock Price
1,078.65
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 275.39B, an increase of 816,954.95%. That is a compound annual growth rate of 469.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 275.39B | -5.00% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 17.50T |
| HDFC Bank | 14.47T |
| Tata Consultancy Services | 12.45T |
| Bharti Airtel | 11.08T |
| ICICI Bank | 9,900.86B |
| State Bank of India | 6,954.51B |
| Infosys | 6,247.86B |
| Hindustan Unilever | 5,481.36B |